| ACR | Aclarubicin |
|---|
| aclarubicin | <chemical> An anthracycline antibiotic produced by streptomyces galilaeus. It has potent antineoplastic activity, especially in the treatment of leukaemias, with reduced cardiac toxicity in comparison to daunorubicin or doxorubicin. Pharmacological action: antibiotics, anthracycline. Chemical name: 1-Naphthacenecarboxylic acid,(2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, methyl ester, (1R-(1alpha,2beta,4beta))- (12 Dec 1998) |
|---|
Synonyms : Aclacin, Aclaplastin, Lundbeck Brand of Aclarubicin Hydrochloride, MA-144A1, Medac Brand of Aclarubicin Hydrochloride, NSC-208734, MA 144A1, MA144A1, NSC 208734, NSC208734
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
¿¡À̺ñ½Å120mgÁÖ»ç - »õâ
|
µ¿±¹Á¦¾à |
A00701471 | Aclarubicin HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¾ÆÅ©¶ó½Ã³íÁÖ - »õâ
|
µ¿¾ÆÁ¦¾à |
A01504171 | Aclarubicin HCl | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|